Barclays PLC Absci Corp Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Absci Corp stock. As of the latest transaction made, Barclays PLC holds 72,111 shares of ABSI stock, worth $303,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,111
Previous 111
64864.86%
Holding current value
$303,587
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ABSI
# of Institutions
119Shares Held
45.7MCall Options Held
426KPut Options Held
123K-
Redmile Group, LLC San Francisco, CA8.25MShares$34.7 Million1.85% of portfolio
-
Fred Alger Management, LLC New York, NY7.41MShares$31.2 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.45MShares$14.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.28MShares$13.8 Million0.13% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.77MShares$7.45 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $391M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....